Free Shipping Canada-wide on orders over $149.
Free Shipping Canada-wide on orders over $149.
Lab X Peptides stands behind this next-generation triple-agonist peptide with a commitment to uncompromising quality and research integrity. Widely studied in metabolic research, all peptides are sourced through WHO/GMP and ISO 9001:2015 certified manufacturing partners to ensure exceptional purity and consistency. Each batch undergoes rigorous quality control testing to maintain accuracy and reliability for research applications. LabX Peptides prioritizes transparent standards and dependable sourcing so researchers can work with complete confidence.
ARA-290 is a synthetic research peptide derived from the tissue-protective region of erythropoietin. It is studied in controlled models involving the innate repair receptor, inflammatory signaling, peripheral-nerve pathways, and tissue response.
Researchers use ARA-290 in preclinical settings to examine tissue-protective signaling without the red-blood-cell stimulation associated with erythropoietin.
This ARA-290 peptide is supplied in a 15mg lyophilized vial and is third-party tested for research quality.
For laboratory research use only. Not for human consumption, medical use, or diagnostic purposes.
Orders are processed promptly and shipped through trusted carriers to ensure timely, secure, and dependable delivery.